Itrizole and hepatic function abnormal 
Itrizole and hepatic function abnormal Patient Reports February 13, 2012
Itrizole Side Effects Report #5594428-4
Itrizole side effect was reported by a Physician from JAPAN on Jan 07, 2008. Male patient, weighting 154.3 lb, was diagnosed with prophylaxis, multiple myeloma
, purpura and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, hepatic function abnormal, platelet count decreased, purpura, pyrexia, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with VELCADE, SULFAMETHOXAZOLE WITH TRIMETHOPRIM, AZULENE, DEPRODONE PROPIONATE. Patient recovered.Itrizole Side Effects Report #5605650-2
Itrizole side effect was reported by a Physician from JAPAN on Jan 21, 2008. Male patient, weighting 154.3 lb, was diagnosed with prophylaxis, multiple myeloma
, purpura and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, hepatic function abnormal, platelet count decreased, purpura, pyrexia, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with VELCADE, SULFAMETHOXAZOLE WITH TRIMETHOPRIM, AZULENE, DEPRODONE PROPIONATE. Patient recovered.Itrizole Side Effects Report #5804741-0
Itrizole side effect was reported by a Physician from JAPAN on July 01, 2008. Male patient, weighting 154.3 lb, was diagnosed with prophylaxis, multiple myeloma
and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, c-reactive protein increased, hepatic function abnormal, neutrophil count decreased, platelet count decreased, purpura, pyrexia, respiratory disorder, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with VELCADE. Patient recovered.Itrizole Side Effects Report #4710467-7
Itrizole side effect was reported by a Physician from JAPAN on June 28, 2005. Female patient, 38 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: abdominal pain lower, haemorrhagic ovarian cyst, hepatic function abnormal. Itrizole dosage: unknown. During the same period patient was treated with CLOMIPHENE CITRATE, CABERGOLINE. Patient recovered.
Itrizole Side Effects Report #4714958-4
Itrizole side effect was reported by a Physician from JAPAN on July 05, 2005. Female patient, 38 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: abdominal pain lower, haemorrhagic ovarian cyst, hepatic function abnormal. Itrizole dosage: unknown. During the same period patient was treated with CLOMIPHENE CITRATE, CABERGOLINE. Patient recovered.
Itrizole Side Effects Report #4753581-2
Itrizole side effect was reported by a Physician from JAPAN on Aug 16, 2005. Female patient, 38 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: abdominal pain lower, haemorrhagic ovarian cyst, hepatic function abnormal. Itrizole dosage: unknown. During the same period patient was treated with CLOMIPHENE CITRATE, CABERGOLINE. Patient recovered.
Itrizole Side Effects Report #6092746-7
Itrizole side effect was reported by a Physician from JAPAN on Dec 25, 2008. Male patient, weighting 132.3 lb, was diagnosed with infection prophylaxis, multiple myeloma
, ph urine increased, antifungal prophylaxis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: diarrhoea, faecal incontinence, hepatic function abnormal, ileus, injection site rash, jaundice , neurogenic bladder, neuropathy peripheral, phlebitis. Itrizole dosage: unknown. During the same period patient was treated with VELCADE, DECADRON, LOXONIN, MEYLON, BACTRIM. Patient recovered.Itrizole Side Effects Report #5826638-2
Itrizole side effect was reported by a Physician from JAPAN on July 25, 2008. Male patient, weighting 105.8 lb, was diagnosed with bronchopulmonary aspergillosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: hepatic function abnormal, myelodysplastic syndrome, renal impairment. Itrizole dosage: unknown. Patient died on 06/19/2008.
Itrizole Side Effects Report #5835118-X
Itrizole side effect was reported by a Physician from JAPAN on Aug 01, 2008. Male patient, weighting 105.8 lb, was diagnosed with bronchopulmonary aspergillosis, anorexia, hypovitaminosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: hepatic function abnormal, myelodysplastic syndrome, renal impairment. Itrizole dosage: unknown. During the same period patient was treated with MAINTENANCE MEDIUM, NEOLAMIN. Patient died on 06/19/2008.
Itrizole Side Effects Report #4543184-7
Itrizole side effect was reported by a Physician from on Dec 20, 2004. Male patient, 69 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, bradycardia, gamma-glutamyltransferase increased, hepatic function abnormal, ileus, nausea
. Itrizole dosage: unknown. During the same period patient was treated with DOXAZOSIN MESYLATE, FAMOTIDINE, NIFEDIPINE, CANDESARTAN CILEXETIL. Patient was hospitalized. Patient recovered.Itrizole Side Effects Report #5197728-5
Itrizole side effect was reported by a Physician from JAPAN on Dec 25, 2006. Male patient, 67 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: hallucination, auditory, hepatic function abnormal, malaise, neuropathy peripheral, somnolence. Itrizole dosage: unknown. During the same period patient was treated with CLARITHROMYCIN, MYSLEE, PREDNISOLONE, GASTER, LEVOFLOXACIN. Patient recovered.
Itrizole Side Effects Report #5139955-9
Itrizole side effect was reported by a Physician from JAPAN on Oct 20, 2006. Female patient, 67 years of age, was diagnosed with nail tinea and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood glucose increased, hepatic function abnormal. Itrizole dosage: unknown. Patient recovered.
Itrizole Side Effects Report #5146004-5
Itrizole side effect was reported by a Physician from JAPAN on Oct 31, 2006. Female patient, 67 years of age, was diagnosed with nail tinea and was treated with Itrizole. After drug was administered, patient experienced the following side effects: hepatic function abnormal. Itrizole dosage: unknown. During the same period patient was treated with FLEROXACIN, HUSCOBRON, CONTOL. Patient recovered.
Itrizole Side Effects Report #5524556-0
Itrizole side effect was reported by a Physician from JAPAN on Nov 14, 2007. Female patient, 66 years of age, was diagnosed with nail tinea, tinea pedis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blood pressure increased, hepatic function abnormal, oedema, pain
. Itrizole dosage: unknown. During the same period patient was treated with ASTAT. Patient recovered.Itrizole Side Effects Report #4714274-0
Itrizole side effect was reported by a Pharmacist from JAPAN on June 28, 2005. Female patient, 64 years of age, was diagnosed with onychomycosis, constipation
, breast cancer , paronychia and was treated with Itrizole. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, ANASTROZOLE, CEFPODOXIME PROXETIL. Patient recovered.Itrizole Side Effects Report #5044761-X
Itrizole side effect was reported by a Physician from JAPAN on June 27, 2006. Female patient, 60 years of age, was diagnosed with nail tinea, hypertension and was treated with Itrizole. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatic function abnormal, hypotension. Itrizole dosage: unknown. During the same period patient was treated with BENIDIPINE HYDROCHLORIDE, CANDESARTAN CILEXETIL. Patient recovered.
Itrizole Side Effects Report #4691012-1
Itrizole side effect was reported by a Physician from on May 30, 2005. Female patient, 54 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: anaemia, brain natriuretic peptide increased, hepatic function abnormal, white blood cell count increased. Itrizole dosage: unknown. During the same period patient was treated with TERBINAFINE. Patient recovered.
Itrizole Side Effects Report #5908249-3
Itrizole side effect was reported by a Physician from JAPAN on Sept 26, 2008. Male patient, 50 years of age, was treated with Itrizole. After drug was administered, patient experienced the following side effects: c-reactive protein increased, hepatic function abnormal, pulmonary haemorrhage, pyrexia. Itrizole dosage: unknown. During the same period patient was treated with CRAVIT, FLUCONAZOLE, MEROPEN, IFOSFAMIDE, CEFPIROME SULPHATE, COTRIM, DEXAMETHASONE, METHOTREXATE. Patient died.
Itrizole Side Effects Report #5933587-8
Itrizole side effect was reported by a Physician from JAPAN on Oct 22, 2008. Male patient, 50 years of age, was treated with Itrizole. After drug was administered, patient experienced the following side effects: c-reactive protein increased, hepatic function abnormal, pulmonary haemorrhage, pyrexia, zygomycosis. Itrizole dosage: unknown. During the same period patient was treated with CRAVIT, FLUCONAZOLE, MEROPEN, IFOSFAMIDE, CEFPIROME SULPHATE, COTRIM, DEXAMETHASONE, METHOTREXATE. Patient died.
Itrizole Side Effects Report #4758568-1
Itrizole side effect was reported by a Physician from JAPAN on Aug 18, 2005. Female patient, 50 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: hepatic function abnormal, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with BUTENAFINE HYDROCHLORIDE, BIFONAZOLE. Patient recovered.
Itrizole Side Effects Report #4791823-8
Itrizole side effect was reported by a Physician from JAPAN on Sept 29, 2005. Female patient, 50 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, hepatic function abnormal, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with BUTENAFINE HYDROCHLORIDE, BIFONAZOLE. Patient recovered.
Itrizole Side Effects Report #4791824-X
Itrizole side effect was reported by a Physician from JAPAN on Sept 29, 2005. Female patient, 50 years of age, was diagnosed with onychomycosis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal, white blood cell count decreased. Itrizole dosage: unknown. During the same period patient was treated with BUTENAFINE HYDROCHLORIDE, BIFONAZOLE. Patient recovered.
Itrizole Side Effects Report #5662402-5
Itrizole side effect was reported by a Physician from JAPAN on Mar 04, 2008. Female patient, weighting 92.59 lb, was diagnosed with systemic mycosis, prophylaxis and was treated with Itrizole. After drug was administered, patient experienced the following side effects: hepatic function abnormal, renal impairment. Itrizole dosage: unknown. During the same period patient was treated with UNASYN, DALACIN. Patient recovered.
Itrizole Side Effects Report #6022292-8
Itrizole side effect was reported by a Physician from JAPAN on Dec 22, 2008. Female patient, weighting 132.3 lb, was diagnosed with onychomycosis, hypertension, hyperlipidaemia and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blister, cellulitis
, hepatic function abnormal, oedema, vasculitis . Itrizole dosage: unknown. During the same period patient was treated with NORVASC, MEVALOTIN, BUFFERIN, CETIRIZINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Itrizole Side Effects Report #6043741-5
Itrizole side effect was reported by a Physician from JAPAN on Jan 15, 2009. Female patient, weighting 132.3 lb, was diagnosed with onychomycosis, hypertension, hyperlipidaemia and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blister, cellulitis
, hepatic function abnormal, infection , oedema, skin ulcer, vasculitis . Itrizole dosage: unknown. During the same period patient was treated with NORVASC, MEVALOTIN, BUFFERIN, CETIRIZINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Itrizole Side Effects Report #6055216-8
Itrizole side effect was reported by a Physician from JAPAN on Jan 26, 2009. Female patient, weighting 132.3 lb, was diagnosed with onychomycosis, hypertension, hyperlipidaemia and was treated with Itrizole. After drug was administered, patient experienced the following side effects: blister, cellulitis
, hepatic function abnormal, infection , oedema, skin ulcer, vasculitis . Itrizole dosage: unknown. During the same period patient was treated with NORVASC, MEVALOTIN, BUFFERIN, CETIRIZINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.